Funding opportunities

ERDERA Joint Transnational Call 2026

On 10 December 2025, ERDERA will launch its 2026 Joint Transnational Call, “Resolving unsolved cases in rare genetic and non‑genetic diseases through variant validation and new technological approaches”.

The call will welcome proposals focused on providing diagnostic clarity in unsolved rare genetic and non‑genetic diseases.

This call’s  pre‑announcement is available below, and it describes the forthcoming opportunity for multinational research teams to apply and will be updated with the full call when it launches.

An information webinar for potential applicants will take place on 16 December, 15:00–17:00 CET. 

ERDERA Networking Support Scheme

A competitive funding instrument for networking events to share knowledge on rare diseases and rare cancers

Through this constantly open call, ERDERA supports the organisation of transnational networking events that promote knowledge sharing, research uptake and collaborations among clinicians, researchers, and patients/patient advocacy organizations (PAOs).

These events will strengthen new or expanding research networks on rare diseases and rare cancers in general and promote the inclusion of typically underrepresented countries (UCs) in European rare diseases and rare cancers networks in particular.

With funding of up to €30 000 per networking event, the scheme has been open since May 2025, offering a flexible framework for building the connections essential to meaningful knowledge sharing in rare disease and rare cancers research.

EP PerMed – Research Innovation and Technology Call for Proposals (RITC) 2026

The European Partnership for Personalised Medicine, EP PerMed (supported by the European Union under Horizon Europe, Grant Agreement N° 101137129), is a platform for joint programming of national and European regional research and innovation supporting activities putting into action “The Strategic Research & Innovation Agenda (SRIA) for Personalised Medicine (2023)”, SRIA for PM (2023), through dedicated research, development and innovation funding.

EP PerMed funding organisations agreed to launch a Research, Innovation and Technology Call (RITC) 2026, co-funded by the EU, to fund multinational, innovative research projects in personalised medicine, which should bring together teams from clinical/public health sector and enterprises as well as academic and non-for-profit teams. The RITC2026 will be conducted simultaneously by the participating funding organisations in their respective region/country and coordinated centrally by the Joint Call Secretariat (JCS), hosted by the French National Research Agency (ANR), France.

The call will be implemented in two stages, i.e. a pre- and a full-proposal phase. The available budget for this call is 13 Mio. € (approx.).

An information day introducing the RITC2026 to the research community will be organised on 28 October 2025. More details (including the registration) will follow soon.

IHI call 12

Call 12

The IHI call 12, a single-stage call for proposal, is scheduled for launch in early 2026. The draft text of IHI call 12 is now available for download

Calls of the European Commission

Please find here the links to calls of the European Commission you can apply to:

• HaDEA Calls for Proposals on Health
• Horizon Europe calls for Funding on Health
  • The new work programmes 2025 under Horizon Europe have been published (see Cluster 1 for health)